Martin Carroll, Director at Mallinckrodt, holds 32.73K shares in Catalent (Ticker: CTLT), holds 64.65K shares in Esperion (Ticker: ESPR), holds 106.86K shares in TherapeuticsMD (Ticker: TXMD).
Martin Carroll latest transaction was an Uninformative Buy of ―.
What was Martin Carroll's most profitable transaction?
Martin Carroll’s most profitable transaction was an Informative Sell of MNKKQ stock on March 16, 2021. The return on the trade was 68.10%.
What is Martin Carroll's role in Mallinckrodt?
Martin Carroll's role in Mallinckrodt is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.